Given that the primary objective of this study was to underscore the diagnostic uncertainty of endometrial sampling, it would be interesting whether the accuracy in diagnosing histological subtype or tumor grading can be enhanced by considering immunohistochemistry markers, such as p53, ki67 or mismatch repair status. The gene discussed is MKI67; the disease is neoplasm.